Sweep 1.3 Flashcards
• Chronic myelogenous leukemia (CML)- ——— implicated.
immature hematopoietic cell
Chronic myelogenous leukemia (CML): is a Clonal proliferation of
immature granulocytes (stem cell disorder).
Chronic myelogenous leukemia (CML): in this you see: Marked increase in
white blood cell count with eosinophilia and basophilia.
Chronic myelogenous leukemia (CML): ——- typically present, stem cell pool ——-
Splenomagaly, 10-20x normal
Chronic myelogenous leukemia (CML): o Unresponsive to normal
growth regulation
Chronic myelogenous leukemia (CML): o Increased peripheral
white cell count with all myeloid cell types present
Chronic myelogenous leukemia (CML): o ————- present in all proliferating cells due to fusion of ——- genes, which mimic the effects of growth factor activation, driving the proliferation of CML
Philadelphia chromosome abnormality
BCR-ABL
Chronic myelogenous leukemia (CML): • While this fusion gene (BCR-ABL) is always present in CML, it is not
unique to this disorder
BCR-ABL: which mimic the
effects of growth factor activation
o CML accounts for about —–of chronic leukemias, and usually occurs in adults from ——– of age
1/3rd, 25-60 years
Chronic myelogenous leukemia: The terminal phase of the disease marked by a relative increase in—— and decreased ———–. Known as:
immature cells in peripheral blood and bone marrow, and decreased response to treatment, is known as blast crisis. This stage is equivalent to an acute leukemia, and is of myeloid lineage in 2/3 and of lymphoid lineage in 1/3.
Blast crisis: CML: This stage is equivalent to an
acute leukemia, and is of myeloid lineage in 2/3 and of lymphoid lineage in 1/3.
CML o Treatment-
targeted inhibitors of the BCR-ABL tyrosine kinase, which induce complete remission in a high percentage of patients.
CML: With relapsed or resistant disease, ——– may be performed, although this is risky in older patients
bone marrow transplant
• Multiple myeloma- proliferating cell is ———, ——— in the rest it is usually only ——- light chain rarely any of the others.
plasma cell that produces Ig.
60% IgG, 20-25% IgA
kappa or lambda
Multiple Myeloma: Find excess ——- in pts, pts can excete the low molecular weight light chains in ——.
Ig, urine
Multiple Myeloma: o Bone resorption results from secretion of
osteoclast activating factors by the myeloma cells
Multiple Myeloma o Proteinaceous casts may form in
kidneys (myeloma kidney)
Multiple Myeloma: ——– often present
o Hypercalcemia present often
Multiple Myeloma: o Pts present with
bone pain, hypercalcemia and renal disease
Multiple Myeloma: Diagnosis:
o Documenting monoclonal protein and skeletal lesions makes the diagnosis